Phase 3 Safety and Efficacy Study of I.V. Iclaprim v Linezolid in cSSSI (ASSIST-1)

Clinical trial NCT00299520 · COMPLETED

Trial details

NCT number: NCT00299520
Sponsor: Arpida AG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Complicated Skin and Skin Structure Infection

Start date: 2005-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.